yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Highly Acclaimed MD Joins Company's Leadership Team

HUNTINGTON BEACH, Calif., Jan. 8, 2013 /PRNewswire/ -- Absorption Pharmaceuticals, makers of the world's first FDA-Approved topical treatment for premature ejaculation, Promescent, announced today that Laurence A. Levine, MD will assume the role of Chief Medical Officer (CMO). Dr. Levine will oversee the company's growth and education efforts, with a focus on getting Promescent written into protocols as a top-line treatment for premature ejaculation nationwide.  

"We're thrilled to have such a highly respected and knowledgeable physician join our team," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "We have been growing rapidly due to Promescent's proven effectiveness and securing Dr. Levine– whom has already provided invaluable assistance in reaching key opinion leaders in sexual medicine– adds to the credibility of this revolutionary product in the sexual medicine category. We look forward to the ongoing adoption of Promescent as the primary medical solution for premature ejaculation."  

Dr. Levine received his medical degree from the University of Colorado Medical School, followed by a residency in general surgery at Tufts-New England Medical Center and in urology at the Harvard Program in Urology at Brigham and Women's Hospital in Boston.  He has made a substantial contribution to the medical press in the form of peer-reviewed articles, books, book chapters, and Internet publications regarding male sexual dysfunction, fertility, chronic orchialgia and reconstructive urology. Currently, Dr. Levine is a professor  of urology at the Rush University Medical Center in Chicago, and is in private practice with Uropartners, LLC. He has received multiple awards and honors; and served as a past-president of the Sexual Medicine Society of North America and the Chicago Urological Society.

"I am very excited to join Absorption Pharmaceuticals as Chief Medical Officer," says Dr. Levine. "Promescent is a ground-breaking, unrivaled product and doctors across the country are delighted to have a solution to a problem that previously has not received the attention it deserves. As an early adopter of the product as treatment for my patients with PE, I'm proud to lead the charge in spreading awareness of Promescent to the medical community."

Created by a urologist, Promescent is a lidocaine-based spray for premature ejaculation designed to absorb below the surface of the skin where nerve endings that control ejaculation are located, ultimately prolonging the time period of intercourse.

Promescent is available through doctors' offices, pharmacies and online at

For more information on Dr. Levine, go to

About Absorption Pharmaceuticals:

Absorption Pharmaceuticals is the maker of Promescent, the world's first FDA-approved topical treatment for premature ejaculation.  Based in Huntington Beach, California, the company was founded in 2011 and has seen tremendous growth including distribution in doctors' offices, pharmacies, and online at

For more information contact:
Susan Weingram 
Tel: 212-584-4271

SOURCE Absorption Pharmaceuticals

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest AJAXWorld RIA Stories
Interested in leveraging automation technologies and a cloud architecture to make developers more productive? Learn how PaaS can benefit your organization to help you streamline your application development, allow you to use existing infrastructure and improve operational efficie...
The OpenStack cloud operating system includes Trove, a database abstraction layer. Rather than applications connecting directly to a specific type of database, they connect to Trove, which in turn connects to one or more specific databases. One target database is Postgres Plus Cl...
"We provide a web application framework for building really sophisticated web applications that run on a browser without any installation need so we get used for biotech, defense, and banking applications," noted Charles Kendrick, CTO and Chief Architect at Isomorphic Software, i...
SYS-CON Events announced today that the "First Containers & Microservices Conference" will take place June 9-11, 2015, at the Javits Center in New York City. The “Second Containers & Microservices Conference” will take place November 3-5, 2015, at Santa Clara Convention Center, S...
DevOps Summit at Cloud Expo New York is offering a limited time FREE "Expo Plus" registration option in New York. On site registration price of $1,95 will be set to 'free' for delegates who register during special offer. To take advantage of this opportunity, attendees can use th...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers